genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Cancer
Mutant Proteins Gum Up Nucleolus, Cause Rare Genetic Disease
Artificial Intelligence
Machine Learning Can Speed Search for Biopharmaceuticals for Oral Delivery
Genomics
Sand, Sea, and Sequencing: Julianna LeMieux Surfs up AGBT’s Hot News
Biologics
Early Anti-VEGF Treatment of Diabetic Retinopathy Does Not Benefit Visual Acuity,…
Cancer
Strata Oncology Validates Clinical Utility of Solid Tumor Predictive Biomarker
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
Artificial Intelligence
Machine Learning Can Speed Search for Biopharmaceuticals for Oral Delivery
Bioprocessing
Out-of-Balance Manufacturing Challenges Bioindustry CFOs
Bioprocessing
University Creates Innovative Model for Running a GMP Manufacturing Facility
Bioprocessing
Monitoring Biomanufacturing Systems and Operations More Effectively
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Home
Companies
Merck & Co
Merck & Co
23andMe
Abbvie
AdnaGen
Agilent Technologies
Alexion Pharmaceuticals
Amgen
Astellas
AstraZeneca
Audentes Therapeutics
Berkeley Lights
Bio-Rad Laboratories
Biogen
Cancer Genetics
Catalent
Charles RIver Laboratories
Dana-Farber Cancer Institute
deCODE genetics
Dicerna
Dimension Therapeutics
Exact Sciences
Foundation Medicine
GE Healthcare
GeneInsight
Gilead Sciences
GlaxoSmithKline
Halozyme Therapeutics
Hitachi High-Technologies
Horizon Discovery Group
Human Longevity
Illumina
Jackson Laboratory
Janssen Biotech
LabCorp
Maravai LifeSciences
MD Anderson
MDxHealth
MedImmune
Memorial Sloan Kettering Cancer Center
Merck & Co
Merck KGaA
NanoString Technologies
Novartis
Pathology
PerkinElmer
PersonalizeDx
Qiagen
RayBiotech
Roche
Sanofi
shire
Sigma-Aldrich
Synthego
Takeda
Thermo Fisher Scientific
UCB Biosciences
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Antibodies
Absci Pursues Google-Sized Ambitions in Drug Discovery, Manufacturing
Cancer
StockWatch: Moderna Cancer Vaccine Propels 72% Surge
Lung Cancer
StockWatch: Summit Nearly Triples on Up-to-$5B Cancer Alliance with Akeso
Eye Disorders
StockWatch: Failed Trial Sinks NGM Bio; Will Merck Opt Into Eye Disorder Drug?
mRNA
StockWatch: Moderna Shares Rise as Merck Opts Into Cancer Vaccine
Immuno-oncology
StockWatch: Checkmate Shares Quadruple on Regeneron Buyout
Immuno-oncology
Regeneron to Acquire Checkmate for $250M, Expanding Cancer I/O Pipeline
Vaccine Development
Patch Position: Vaxxas Licenses UT Austin Vaccine for Clinical Trials
Small Molecules
Looking Beyond the Curve: Merck Inks Up-to-$1.7B Small Molecule Partnership
HBV
And Then There Were Four: VBI Scores First FDA Approval with...
Coronavirus
“Game Changer:” After Vaccines, Pfizer Stakes Claim in COVID-19 Drugs, Too
Merck & Co
Merck to Seek FDA EUA for COVID-19 Pill after Positive Phase...
Merck & Co
Merck & Co. to Acquire Acceleron for $11.5B
Merck & Co
‘Manufacturing-First Approach’ Pays Off for Cell Therapy Developer Artiva
Merck & Co
Merck Halves COVID-19 Pipeline; Halts Two Vaccines, Continues Two Drugs
1
2
3
...
5
Page 1 of 5
Scroll Up
Login
Subscribe